Archive for the ‘Hypertension’ Category
Thursday, February 21st, 2008
Women who drank more fat free milk and had higher intakes of calcium and vitamin D from foods, and not supplements, tended to have a lower risk for developing hypertension or high blood pressure, according to a new study published in the American Heart Association journal, Hypertension.
After examining the diets ...
Posted in Hypertension | No Comments »
Tuesday, February 19th, 2008
King Pharmaceuticals, Inc. (NYSE: KG) announced the launch of its new ALTACE(R) Tablets (ramipril). King has received orders and initiated shipments of ALTACE(R) Tablets to many of its customers. The Company will continue to make available ALTACE(R) Capsules (ramipril).
About ALTACE
ALTACE is the leading branded ACE inhibitor with multiple indications. ALTACE ...
Posted in Hypertension | No Comments »
Saturday, February 9th, 2008
In a study of pregnant women, those with pregnancy-induced high blood pressure were found to have higher levels of a peptide that raises blood pressure in the pieces of tissue linking mother and fetus, according to researchers at Wake Forest University Baptist Medical Center. The finding, reported online in the ...
Posted in Hypertension | No Comments »
Wednesday, November 7th, 2007
Prof. Juerg Nussberger, MD, University Hospital of the Canton of Vaud (CHUV), in Lausanne, Switzerland, presents today detailed results of a placebo-controlled, double-blind phase IIa clinical trial with CYT006-AngQb in 72 patients with mild to moderate hypertension. In addition, the American Heart Association publishes today at the time of presentation ...
Posted in Hypertension | No Comments »
Thursday, November 1st, 2007
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valsartan Tablets, 40 mg, 80 mg, 160 mg and 320 mg. Total annual market sales for Valsartan Tablets were ...
Posted in Hypertension | No Comments »
Thursday, October 25th, 2007
The investigational antihypertensive drug Cleviprex™ (clevidipine butyrate injectable emulsion) rapidly reduced blood pressure and maintained blood pressure control in patients presenting to the emergency department with acute hypertension, according to data from the Phase III trial VELOCITY* presented today at the annual meeting of the American College of Chest Physicians ...
Posted in Hypertension | No Comments »
Sunday, September 30th, 2007
Blood flow to the parts of the brain that support memory function differs between people with high blood pressure and those with normal blood pressure, and this difference seems to increase when high blood pressure is treated with medications, researchers reported at the American Heart Association's 61st Annual Fall Conference ...
Posted in Hypertension | No Comments »
Friday, September 28th, 2007
Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced confirmation of the ability of PS433540 (DARA) to block the angiotensin II (AII) response in a Phase 1 trial in healthy volunteers. Numerous similar studies with other agents ...
Posted in Hypertension | No Comments »
Friday, September 28th, 2007
Daiichi Sankyo, Inc. announced that the United States Food and Drug Administration (FDA) has approved AZOR(TM) (amlodipine and olmesartan medoxomil) for the treatment of hypertension, also known as high blood pressure. AZOR is a convenient, once daily, single tablet combination of amlodipine, the number ...
Posted in Hypertension | No Comments »
